In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...

Firms like Moderna that are rapidly adopting AI and will have a higher mix of AI software robots to humans in the future ...

Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than three years ago. Indeed, if you axed Moderna off your watchlist after the ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The S&P 500 fell 0.1% on Tuesday, July 8, 2025, after President Trump extended the deadline for "reciprocal" tariffs and ...

We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy. Regardless of what happens over the next six months, it's still worth it to invest ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID shot. The question is whether it gets approved for both viruses. Why it ...

However, Richard Hughes IV, a lawyer at Epstein Becker & Green PC and former Moderna Inc. executive, said it would take time for the change to happen. The removal of financial protections for ...

Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates May 01, 2025 6:30 AM ET Moderna, Inc. (MRNA) ...

Moderna's RSV vaccine for adults aged 60 years and older has been recently approved in Australia, Switzerland, Taiwan and the UK. First Quarter 2025 Financial Results ...